12:00 AM
 | 
Aug 13, 2012
 |  BC Week In Review  |  Company News  |  Other News

Forest Laboratories generics, pharmaceuticals news

Forest and Carl Icahn issued dueling statements ahead of the company's Aug. 15 annual meeting, where the activist investor will seek to install his slate of four directors on Forest's board. Icahn claims Forest is preventing him from disclosing to shareholders details on change-of-control provisions in certain undisclosed deals, as well as another undisclosed issue that Icahn called a "smoking gun." Icahn is seeking...

Read the full 296 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >